Telmisartan Plus Tablet 40/12.5mg

Adult dosage

For patients whose blood pressure cannot be adequately controlled with telmisartan alone, this medication is taken once daily with water, regardless of food intake. The dosage of each component should be adjusted individually, and when clinically appropriate, direct transition from monotherapy to this combination therapy may be considered. - The Telmisartan/Hydrochlorothiazide combination 40/12.5mg may be prescribed to those who cannot adequately control their blood pressure with 40mg of telmisartan alone.

Children's dosage

The safety and efficacy of this medication have not been established for children under 18 years of age.

This medication should not be used during pregnancy, especially during the second and third trimesters, as it can cause serious harm to the fetus. It should not be administered to individuals with allergies to the active ingredients or excipients, those with hypersensitivity to certain sulfonamide drugs, pregnant women in the second and third trimesters, nursing mothers, individuals with obstructive biliary disease, or patients with severe liver or kidney dysfunction. Caution is advised when using this drug in elderly patients or those with high potassium levels, liver impairment, heart valve disease, or ischemic heart disease, and it is necessary to regularly monitor skin condition due to the risk of skin cancer. Side effects such as dizziness, hypotension, nausea, muscle cramps, and rashes may occur, and in rare cases, serious allergic reactions or liver dysfunction may also arise. As this drug lowers blood pressure, it may cause hypotension and electrolyte imbalance, so regular blood tests should be conducted to check potassium, sodium, and other levels. Especially, this drug can interact with other antihypertensive medications, diuretics, lithium, and nonsteroidal anti-inflammatory drugs, so it is essential to consult with a doctor or pharmacist if taking other medications. If planning to become pregnant or upon confirmation of pregnancy, this medication should be discontinued immediately, and consultation with a physician is recommended. It is also advisable not to take this drug while breastfeeding. In the case of overdose, symptoms such as hypotension, cardiac arrhythmias, and electrolyte abnormalities may occur, and immediate medical attention should be sought if symptoms arise. This drug is not recommended for children under 18, as its safety and effectiveness have not been established. Elderly patients should be careful to avoid excessive hypotension.

Serious side effects

• Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe allergic reactions.
• Angioedema (may lead to fatal outcomes).
• Severe rash accompanied by high fever, blistering, peeling skin, pain in mucous membranes of mouth/eyes, severe skin adverse reactions.
• Difficulty breathing, respiratory distress (including pneumonia and pulmonary edema), acute respiratory distress syndrome (ARDS), respiratory issues.
• Yellowing of skin or eyes (jaundice), liver dysfunction.

Mild side effects

• Hypokalemia
• hyperuricemia
• hyponatremia
• anxiety
• depression
• dizziness
• insomnia
• sleep disturbances
• visual disturbances
• temporary blurred vision

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to preserve the drug's efficacy and safety.

Appearance

A rectangular tablet consisting of a white and red layer, the white layer may have red specks.

Package unit

30 tablets (10 tablets/PTP×3)